Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.
作者： J.-H. Zhong , L. Ma , L.-C. Wu , W. Zhao , W.-P. Yuan
DOI: 10.1111/J.1742-1241.2011.02814.X
关键词:
摘要: … Wei-Ping Yuan and Fei-Xiang Wu were responsible for statistical methods. Le-Qun Li obtained funding. Jian-Hong Zhong, Liang Ma,Wei Zhao, Zhi-Ming Zhang, Shan Huang and Xue-…
sci-hub.se 参考文章(54)
Paola Olioso, Raffaella Giancola, Maria Di Riti, Alessandro Contento, Patrizia Accorsi, Antonio Iacone, Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial. Hematological Oncology. ,vol. 27, pp. 130- 139 ,(2009) , 10.1002/HON.886
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857
Kazutoshi Ono, Yoshiyuki Yamanaga, Kyousuke Yamamoto, Shun-Ichi Koga, Junji Nishimura, Hajime Nawata, Natural killing activities in chronic liver diseases and hepatocellular carcinoma. Journal of Clinical Immunology. ,vol. 16, pp. 41- 45 ,(1996) , 10.1007/BF01540971
Ann Tan, Federico Aucejo, Richard Kim, Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma Oncology. ,vol. 78, pp. 161- 171 ,(2010) , 10.1159/000315577
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jiejun Wang, Won Young Tak, Hongming Pan, Karin Burock, Jessie Zou, Dimitris Voliotis, Zhongzhen Guan, None, Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncology. ,vol. 10, pp. 25- 34 ,(2009) , 10.1016/S1470-2045(08)70285-7
Sasa-Marcel Maksan, Patrick Morad Araib, Eduard Ryschich, Martha Maria Gebhard, Jan Schmidt, Immune escape mechanism: defective resting and stimulated leukocyte-endothelium interaction in hepatocellular carcinoma of the rat. Digestive Diseases and Sciences. ,vol. 49, pp. 859- 865 ,(2004) , 10.1023/B:DDAS.0000030100.05979.B7
David Moher, Deborah J Cook, Susan Eastwood, Ingram Olkin, Drummond Rennie, Donna F Stroup, Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement The Lancet. ,vol. 354, pp. 1896- 1900 ,(1999) , 10.1016/S0140-6736(99)04149-5
Tim F. Greten, Firouzeh Korangy, Radiofrequency ablation for the treatment of HCC – Maybe much more than simple tumor destruction? Journal of Hepatology. ,vol. 53, pp. 775- 776 ,(2010) , 10.1016/J.JHEP.2010.05.008
Sameer Parikh, David Hyman, Hepatocellular Cancer: A Guide for the Internist The American Journal of Medicine. ,vol. 120, pp. 194- 202 ,(2007) , 10.1016/J.AMJMED.2006.11.020
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 74- 108 ,(2005) , 10.3322/CANJCLIN.55.2.74